In November 2018, Jan Smeitink, founder and CEO of Khondrion attended the 24th Annual BIO-Europe conference in Copenhagen, Denmark. He spoke to Mike Ward, Chief Content Officer at Informa Pharma Insights about his career, Khondrion’s world-leading science in mitochondrial diseases and future development plans.
